Looking to sell Route 92 stock or options?
Route 92 is the developer of an innovative medical device aimed at treating strokes and similar conditions. Their device features a percutaneous catheter for addressing acute ischemic stroke, a rapid aspiration thrombectomy system, and a delivery system for intra-cerebral implants. This technology empowers healthcare professionals to effectively treat patients and enhance the recovery process for those overcoming a stroke.
Runway Growth Capital, Novo Holdings, Norwest Venture Partners, U.S. Venture Partners, The Vertical Group, InnovaHealth Partners.
Route 92 is currently a private company. This means that the company is not listed on any public exchange and so there is no public market for its stock. However, there may still be ways to monetize Route 92 stock. Depending on Route 92’s policies, you may be able to: (1) find a private buyer in the secondary market to purchase your stock, (2) borrow against your stock, or (3) exchange Route 92 stock into the Collective Exchange Fund for a limited partnership interest and then borrow non-recourse against your interest to generate immediate cash. This last alternative can be much quicker and net you more after-tax cash than your other options. An exchange into our fund also reduces your risk by diversifying your holdings out of an over-concentrated position.
Collective Liquidity can provide liquidity to shareholders of Route 92 stock in two ways. First, Route 92 employees can exchange shares into the Collective Exchange Fund and then borrow non-recourse to generate immediate cash. This can net you more after-tax cash than a stock sale. It also reduces your risk by diversifying your holdings out of an over-concentrated position. In some cases, Collective may also be able to purchase your Route 92 stock. Note that all transactions in Route 92 shares are subject to the company’s policies regarding secondary transactions. Schedule a call with a Collective Liquidity representative to learn more about your private market liquidity alternatives.
Route 92 stock is not listed on any public exchange and so there is no public market for its shares. Therefore, there is no single, centralized price for Route 92 stock. Typically, shares of private companies like Route 92 are set with buyers in one off negotiations. Collective Liquidity, however, uses a proprietary algorithm to determine its bids so we almost always have an immediately actionable price for you.
On Jun 2024, Route 92 is reported to have closed an equity financing in which the investors valued the company at $251M. This valuation is typically calculated by multiplying the per share price of the preferred stock sold in the financing by the number of Route 92 shares outstanding assuming the conversion of all stock options, warrants, etc.
Tickers are used to identify company’s shares on public markets like the NYSE or Nasdaq. Because Route 92 is not currently publicly traded, it does not have a ticker symbol.
Route 92 has not yet conducted an initial public offering (“IPO”) and so remains a private company. Though Route 92 is a well-known, successful company, there can be no assurance that it will ever go public or be sold. Because of the risk this imposes on Route 92 shareholders, many investors elect to gain liquidity for at least some of their shares before the IPO. Schedule a call with a Collective Liquidity representative to discuss your private market liquidity alternatives.